Diagnosis
Sjogren syndrome
A chronic autoimmune inflammation of the lacrimal and salivary glands with mucosal dryness that manifests as dry eyes and mouth.
Etiology
Cause [vy3]
Unknown
Multifactorial:
Genetic predisposition (HLA-DQB1)
Hormonal
Environmental factors (Epstein-Barr virus)
Classification [vy3]
Primary Sjögren syndrome is a solitary process
Secondary Sjögren syndrome accompanies another autoimmune disease (such as rheumatoid arthritis or systemic lupus erythematosus)
Pathophysiology [vy3]
Environmental insult in genetically predisposed individual
Epithelial damage --> inflammation --> triggers an aberrant autoimmune response
Aggregations of lymphocytes (CD4 T cells, memory cells and B cells)
Exocrine gland dysfunction --> Reduced tear and saliva production
Clinical presentation:
Keratoconjuntivitis sicca: Dry eyes, corneal erosions, vision loss
Xerostomia: Dry mouth, dental caries, dental decay, and tooth loss
Musculoskeletal: Arthritis (16%), arthralgia (96%), myalgia (70%), myositis (rare)
Dermatologic (72%): Xeroderma, eyelid dermatitis, Raynaud phenomenon, cutaneous vasculitis (purpura), cutaneous amyloidosis, and annular erythema
Neurologic (5%): Mild cognitive dysfunction, transverse myelitis, neuromyelitis optica, lymphocytic meningitis, cerebral vasculitis, cranial neuropathies (trigeminal, facial, or cochlear nerves), peripheral neuropathies, small fiber neuropathy, sensory ataxic neuronopathy, mononeuritis multiplex and autonomic dysfunction
Renal (5%): Tubulointerstitial nephritis, distal renal tubular acidosis, membranoproliferative glomerulonephritis
Hematologic: Cytopenias, hypergammaglobulinemia (40%), hypogammaglobulinemia, monoclonal gammopathy, cryoglobulins, leukopenia (20%), anemia (24%), thrombocytopenia (30%)
Pulmonary: Cough/dyspnea related to dryness, bronchiectasis, bronchiolitis, interstitial lung disease (nonspecific interstitial pneumonia, lymphocytic interstitial pneumonia, organizing pneumonia), cystic lung disease, pulmonary hypertension
Non-Hodgkin lymphoma: An 8.7-fold increased risk
Complications [vy3]
Dental caries
Oral infections
Extraglandular manifestations
Non-Hodgkin lymphoma
Epidemiology
Incidence per 100.000 [rzd][ocf][ypp][yfg][bea][ers][ugq]
Symptoms & findings
Symptoms
Arthralgia, Arthritis, Ataxia, Cough, Dysgeusia, Dyspepsia, Fasciculations, Fatigue, Keratoconjunctivitis sicca, Lymphadenopathy, Muscle weakness, Myalgia, Paresis, Paresthesia, Raynaud phenomenon, Red eye, Xeroderma, Xerophthalmia, Xerostomia
Clinical findings
Anemia, Anti-SSA, Anti-SSB, Cryoglobulinemia, Hypergammaglobulinemia
Anamneses
None listed.
Localized findings
Approach
Blood: Anti-RO(SSA), anti-La(SSB), antinuclear anitbody, ANA, rheumatoid factor [pru]
Schirmer test
Salivary gland ultrasonography
Salivary scintigraphy
Sialometry
Salivary gland biopsy: lymphocytic infiltrate, acinar atrophy
Diagnostic criteria [ers]
Ocular symptoms: dry eyes (>3 months), sensation of sand in eyes, use of tear substitutes >3/day
Oral symptoms: dry mouths (>3 months), swollen salivary glands, frequent drinking to aid swallowing dry food
Ocular signs: Schirmer´s I test (≤5mm in 5 min), Rose Bengal score
Histopathology: focal lymfocytic sialoadenitis
Salivary gland: understimulated flow ≤1.5ml in 15 min, parotid sialography showing sialectasias without obstruction, salivary scintigraphy showing delayed uptake/concentration/excretion
Autoantibodies: Anti-RO(SSA) and/or anti-La(SSB)
Diagnostic criteria [vy3]
Suspicion based on at least 1 of the following:
Daily, persistent, troublesome dry eyes
Recurrent sensation of sand or gravel in the eyes
Regular use of tear substitutes
Daily feeling of dry mouth
Frequent need to drink liquids to help swallow dry food
Labial salivary gland biopsy showing focal lymphocytic sialadenitis (3 points)
Positive anti-Ro/SSA or anti-La/SSB antibodies (3 points)
Ocular staining score ≥5 or van Bijsterveld score ≥4 in at least 1 eye (1 point)
Schirmer’s test result ≤5 mm/5 minutes in at least 1 eye (1 point)
Unstimulated whole salivary flow rate ≤0.1 mL/minute (1 point)
Score of ≥4 --> Sjögren syndrome
Treatment
There is no known cure for Sjögren syndrome and treatment focuses on relieving symptoms [vy3]
Xerophthalmia: [vy3]
Topical tear replacement
Topical corticosteroids: risks of glaucoma, cataracts, and infections
Topical cyclosporine or tacrolimus
Xerostomia: [vy3][pru]
Daily topical fluoride use and antimicrobial mouth rinses
Sugar-free chewing gums and sour lemon lozenges for salivary stimulation
Muscarinic agonists pilocarpine or cevimeline stimulate salivary flow
Systemic treatment: if moderate to severe extraglandular manifestations [vy3]
Glucocorticoids
Antimalarial medication (hydroxychloroquine)
Steroid-sparing immunosuppressants: methotrexate, azathioprine, mycophenolate mofetil, leflunomide, rituximab or cyclophosphamide
Differential diagnoses
Allergy, Benign tumors of salivary glands, Blepharitis, Celiac disease, Chronic sinusitis, Conjunctivitis, Diabetes mellitus, Drug side effects, Hashimotos thyroiditis, HIV, Hypovolemia, Lymphoma, Malignant tumors of salivary glands, Mumps, Parkinson's disease, Polyneuropathy, Rheumatoid arthritis, Rosacea, Sarcoidosis, Scleroderma, Sialadenitis, Systemic lupus erythematosus
References
[1] Carsons SE, Blum MA. Sjogren Syndrome. [Updated 2025 Jul 6]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK431049/
[2] Qin B, Wang J, Yang Z, Yang M, Ma N, Huang F, Zhong R. Epidemiology of primary Sjögren's syndrome: a systematic review and meta-analysis. Ann Rheum Dis. 2015 Nov;74(11):1983-9.
[3] Plesivcnik Novljan M, Rozman B, Hocevar A, Grmek M, Kveder T, Tomsic M. Incidence of primary Sjogren's syndrome in Slovenia. Ann Rheum Dis. 2004 Jul;63(7):874-6.
[4] Weng MY, Huang YT, Liu MF, Lu TH. Incidence and mortality of treated primary Sjogren's syndrome in Taiwan: a population-based study. J Rheumatol. 2011 Apr;38(4):706-8.
[5] See LC, Kuo CF, Chou IJ, Chiou MJ, Yu KH. Sex- and age-specific incidence of autoimmune rheumatic diseases in the Chinese population: a Taiwan population-based study. Semin Arthritis Rheum. 2013 Dec;43(3):381-6.
[6] Yu KH, See LC, Kuo CF, Chou IJ, Chou MJ. Prevalence and incidence in patients with autoimmune rheumatic diseases: a nationwide population-based study in Taiwan. Arthritis Care Res (Hoboken). 2013 Feb;65(2):244-50.
[7] Alamanos Y, Tsifetaki N, Voulgari PV, Venetsanopoulou AI, Siozos C, Drosos AA. Epidemiology of primary Sjögren's syndrome in north-west Greece, 1982-2003. Rheumatology (Oxford). 2006 Feb;45(2):187-91.
[8] Pillemer SR, Matteson EL, Jacobsson LT, Martens PB, Melton LJ 3rd, O'Fallon WM, Fox PC. Incidence of physician-diagnosed primary Sjögren syndrome in residents of Olmsted County, Minnesota. Mayo Clin Proc. 2001 Jun;76(6):593-9.
[9] Kruszka P, O'Brian RJ. Diagnosis and management of Sjögren syndrome. Am Fam Physician. 2009 Mar 15;79(6):465-70.
[10] http://emedicine.medscape.com/article/332125 (2014-01-02); [Medscape]